Results for this period
Third quarter1 October 2025 to 30 June 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Expansion of the Group through the consolidation of ファスキアホールディングス and its 3 subsidiaries, as well as solid trends in the promotion of healthcare DX and demand for capital investment by medical institutions. In the Medical Total Solutions Business, the profit margin declined because of a decrease in highly profitable large-scale projects.
No applicable matters.
| Item | Details |
|---|---|
| Fiscal Period Classification | Third quarter |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 October 2025 to 30 June 2026 |
| Net Sales | ¥36,183 million (YoY +110.3%) |
| Operating profit | ¥644 million (YoY +35.7%) |
| Ordinary income | ¥607 million (YoY +23.4%) |
| Profit attributable to owners of the parent | ¥280 million (YoY -11.7%) |
| Net income per share | ¥47.38 |
| Equity ratio | End of the current fiscal period 26.1 / End of previous period 51.8 |
| Total assets | ¥22,296 million |
| Net assets | ¥6,020 million |
| Full-year earnings forecast | Net Sales ¥44,500 million (YoY +107.1%) / Operating profit ¥680 million (YoY +135.9%) / Ordinary income ¥610 million (YoY +97.5%) / Net income ¥230 million (YoY +50.5%) |
| Annual Dividend Forecast | ¥17 → ¥17（0.0%） |
| Segment revenue | Medical Total Solution Business ¥16,116,020 thousand (YoY -1.1%), Remote Diagnostic Imaging Services Business ¥616,496 thousand (YoY +0.4%), Minimally Invasive Medical Device Sales Business ¥17,626,234 thousand, Rental Business ¥467,123 thousand |
| Segment profit | Medical Total Solution Business ¥177,430 thousand (YoY -56.3%), Remote Diagnostic Imaging Services Business ¥59,019 thousand (YoY +0.6%), Minimally Invasive Medical Device Sales Business ¥350,453 thousand, Rental Business ¥62,403 thousand |
| Depreciation and amortization | ¥308,773 thousand |
| Disclosure regarding the going concern assumption | No applicable matters. |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New Number of companies 4 / Company name ファスキアホールディングス株式会社, 株式会社フォーム, 株式会社シンコム, 中京三洋株式会社 / Excluded Number of companies 0 / Company name Not disclosed |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | No |
| Issued Shares at Period-End | 5,922,000 |
| Treasury Shares at Period-End | 237 |
| Factors Behind Changes in Business Performance | Expansion of the Group through the consolidation of ファスキアホールディングス and its 3 subsidiaries, as well as solid trends in the promotion of healthcare DX and demand for capital investment by medical institutions. In the Medical Total Solutions Business, the profit margin declined because of a decrease in highly profitable large-scale projects. |
Items this document does not state (13)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The company said that in October 2025 it made ファスキアホールディングス and its 3 subsidiaries consolidated subsidiaries, expanding the scale of the Group and working to achieve stable performance. It also said that the promotion of healthcare DX and demand for capital investment by medical institutions remained solid. No specific explanation was provided for the decrease in profit attributable to owners of the parent.